# Comparison of Inactivated and Live, Attenuated Influenza Vaccine in Children 5-9 Years of Age-Year 3 Amendment

> **NCT00138385** · PHASE4 · COMPLETED · sponsor: **National Institute of Allergy and Infectious Diseases (NIAID)** · enrollment: 40 (—)

## Conditions studied

- Influenza

## Interventions

- **BIOLOGICAL:** FluMist
- **BIOLOGICAL:** Fluzone

## Key facts

- **NCT ID:** NCT00138385
- **Lead sponsor:** National Institute of Allergy and Infectious Diseases (NIAID)
- **Sponsor class:** NIH
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-08
- **Primary completion:** —
- **Final completion:** 2007-06
- **Target enrollment:** 40 (—)
- **Last updated:** 2010-08-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00138385

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00138385, "Comparison of Inactivated and Live, Attenuated Influenza Vaccine in Children 5-9 Years of Age-Year 3 Amendment". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT00138385. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*